- SciSparc Secures Strategic Advantage with Grant of European Patent
- SciSparc to Acquire AutoMax
- SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
- SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
- SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
- SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
- SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
- SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder
- SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe
- SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
More ▼
Key statistics
As of last trade Scisparc Ltd (SPRC:NAQ) traded at 0.9319, 3.54% above its 52-week low of 0.90, set on May 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.9465 |
---|---|
High | 0.9747 |
Low | 0.91 |
Bid | 0.9195 |
Offer | 0.9499 |
Previous close | 0.9596 |
Average volume | 286.87k |
---|---|
Shares outstanding | 708.44k |
Free float | 708.27k |
P/E (TTM) | -- |
Market cap | 658.85k USD |
EPS (TTM) | -1.22 USD |
Data delayed at least 15 minutes, as of Jun 06 2024 19:09 BST.
More ▼